Additionally, regulation of TRPML1, TRPM2, and TRPM7 activity might also be a therapeutic strategy for ALS (Hermosura and Garruto, 2007; Hermosura et al., 2008; Tedeschi et al., 2019). Here, TRPM2 is linked to amyotrophic lateral sclerosis.